Lv32
270 积分 2026-07-21 加入
Efficacy and safety of low-dose IL-2 in people with newly diagnosed type 1 diabetes (DIABIL-2): a double-blind, multicentre, randomised, placebo-controlled, phase 2b trial
26分钟前
待确认
GPR171 restrains intestinal inflammation by suppressing FABP5-mediated Th17 cell differentiation and lipid metabolism
2天前
已完结
Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
15天前
已完结
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
15天前
已完结
Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity
15天前
已完结
Unsaturated bond recognition leads to biased signal in a fatty acid receptor
1个月前
已完结
Unsaturated bond recognition leads to biased signal in a fatty acid receptor
1个月前
已完结
Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial
1个月前
已完结
The Virtual Biotech: A multi-agent AI framework for therapeutic discovery and development
1个月前
已完结
Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis
2个月前
已完结
皖公网安备34019202002308
